← FDA DRUG APPROVALS

FDA NDA · NDA021408

MENTAX-TC

Sponsor: PHARMOBEDIENT

APPLICATION
NDA021408
TYPE
NDA
ORIGINAL APPROVAL
2002-10-17
LATEST ACTION
2002-10-17
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

MENTAX-TCDiscontinued
BUTENAFINE HYDROCHLORIDE 1% · CREAM · TOPICAL

Approval history

2002-10-17Type 3 - New Dosage Form · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →